61
CanSino
6185.HK·HKEXTianjin CNFounded 20093,000 employees
Mid CapbiotechPublicInfectious Disease
Platform: Ad5-nCoV Vax
Market Cap
$2B
All Drugs
2
Clinical Trials
4
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (6185.HK)
Loading 6185.HK stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| 618-5050 | 618-5050 | Phase 2 | 2 | IL-17A | PsoriasisHemophilia A | ||
| 618-7080 | 618-7080 | Phase 2 | 2 | MDM2 | NSCLCACC |
SEC Filings & Financial Documents
SEC filings are not available for HKEX-listed companies.
CanSino trades on HKEX (CN). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (3)